Advancing Precision Medicine by Enabling a Collaborative Informatics Community
By Taha A. Kass-Hout, M.D., M.S., & David Litwack, Ph.D. – FDA plays an integral role in President Obama’s Precision Medicine Initiative, which foresees the day when an individual’s medical care will be tailored in part based on their unique characteristics and genetic make-up. Yet while more than 80 million genetic variants have been found in the human genome, we don’t understand the role that most of these variants play in health or disease.
Read More